{"pmid":32407967,"title":"COVID-19: an overview of worldwide recommendations for management of patients with liver diseases or liver transplantation.","text":["COVID-19: an overview of worldwide recommendations for management of patients with liver diseases or liver transplantation.","Clin Gastroenterol Hepatol","Perazzo, Hugo","Piedade, Juliana","Castro, Rodolfo","Pinto, Laura","Veloso, Valdilea G","Grinsztejn, Beatriz","Pereira, Gustavo","Fernandes, Flavia F","32407967"],"journal":"Clin Gastroenterol Hepatol","authors":["Perazzo, Hugo","Piedade, Juliana","Castro, Rodolfo","Pinto, Laura","Veloso, Valdilea G","Grinsztejn, Beatriz","Pereira, Gustavo","Fernandes, Flavia F"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32407967","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.cgh.2020.04.074","topics":["Prevention"],"weight":1,"_version_":1666802845433724930,"score":9.490897,"similar":[{"pmid":32277387,"pmcid":"PMC7146012","title":"Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.","text":["Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation.","Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic.","Hepatol Int","Liu, Hongling","He, Xi","Wang, Yudong","Zhou, Shuangnan","Zhang, Dali","Zhu, Jiye","He, Qiang","Zhu, Zhijun","Li, Guangming","Sun, Libo","Wang, Jianli","Cheng, Gregory","Liu, Zhenwen","Lau, George","32277387"],"abstract":["Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic."],"journal":"Hepatol Int","authors":["Liu, Hongling","He, Xi","Wang, Yudong","Zhou, Shuangnan","Zhang, Dali","Zhu, Jiye","He, Qiang","Zhu, Zhijun","Li, Guangming","Sun, Libo","Wang, Jianli","Cheng, Gregory","Liu, Zhenwen","Lau, George"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277387","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s12072-020-10043-z","keywords":["2019-ncov","covid-19","liver transplantation","management"],"locations":["Beijing","China","Beijing"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention","Diagnosis","Treatment"],"weight":1,"_version_":1666138491597094912,"score":71.394905},{"pmid":32489655,"pmcid":"PMC7242013","title":"Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic.","text":["Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic.","Clin Liver Dis (Hoboken)","Lau, George","Ward, John W","32489655"],"journal":"Clin Liver Dis (Hoboken)","authors":["Lau, George","Ward, John W"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32489655","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/cld.972","topics":["Prevention"],"weight":1,"_version_":1668623433604268032,"score":67.15813},{"pmid":32341229,"title":"Saudi association for the study of liver diseases and transplantation position statement on liver transplantation during the COVID-19 pandemic.","text":["Saudi association for the study of liver diseases and transplantation position statement on liver transplantation during the COVID-19 pandemic.","The World Health Organization (WHO), on March 11(th) 2020, upgraded the status of the novel coronavirus disease (COVID-19) from epidemic to pandemic. Over two million individuals have been infected with SARS-CoV-2, the virus causing COVID-19, and as of April, 14(th) 2020, there were over 5000 confirmed cases in Saudi Arabia (SA). Many countries, including SA, have imposed major restrictions on travel, and everyday life, and the implications of these necessary changes are being felt in liver transplant (LT) centers in SA. Concerns remain that there is an increased risk for individuals over 65 years of age, with underlying medical conditions, or for those who are immunocompromised. Therefore, the Saudi Association for the Study of Liver Diseases and Transplantation (SASLT) established an urgent task force to launch a statement that can be utilized by LT centers as a guidance in the management of patients with advanced liver disease from the time of LT listing to the post-operative care of transplanted patients.","Saudi J Gastroenterol","Al-Judaibi, Bandar","Almaghrabi, Reem","Alghamdi, Mohammed","Al-Hamoudi, Waleed K","AlQahtani, Mohammed","Abaalkhail, Faisal","Shagrani, Mohammed","Sanai, Faisal M","32341229"],"abstract":["The World Health Organization (WHO), on March 11(th) 2020, upgraded the status of the novel coronavirus disease (COVID-19) from epidemic to pandemic. Over two million individuals have been infected with SARS-CoV-2, the virus causing COVID-19, and as of April, 14(th) 2020, there were over 5000 confirmed cases in Saudi Arabia (SA). Many countries, including SA, have imposed major restrictions on travel, and everyday life, and the implications of these necessary changes are being felt in liver transplant (LT) centers in SA. Concerns remain that there is an increased risk for individuals over 65 years of age, with underlying medical conditions, or for those who are immunocompromised. Therefore, the Saudi Association for the Study of Liver Diseases and Transplantation (SASLT) established an urgent task force to launch a statement that can be utilized by LT centers as a guidance in the management of patients with advanced liver disease from the time of LT listing to the post-operative care of transplanted patients."],"journal":"Saudi J Gastroenterol","authors":["Al-Judaibi, Bandar","Almaghrabi, Reem","Alghamdi, Mohammed","Al-Hamoudi, Waleed K","AlQahtani, Mohammed","Abaalkhail, Faisal","Shagrani, Mohammed","Sanai, Faisal M"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32341229","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.4103/sjg.SJG_131_20","keywords":["covid-19","cirrhosis","liver transplant"],"locations":["Saudi Arabia","Saudi"],"countries":["Saudi Arabia"],"countries_codes":["SAU|Saudi Arabia"],"topics":["Prevention"],"weight":1,"_version_":1666138495840681985,"score":62.40598},{"pmid":32439237,"title":"Liver transplantation in the era of COVID-19.","text":["Liver transplantation in the era of COVID-19.","Liver transplantation is considered the ultimate solution for patients with end-stage chronic liver disease or acute liver failure. Patients with liver transplant need special care starting from preoperative preparation, surgical intervention ending with postoperative care. Transplanted patients have to receive immunosuppressive therapy to prevent rejection. Such a state of immune suppression could predispose to different types of infections in liver transplant recipients. Currently, the world is suffering a pandemic caused by a new strain of the coronavirus family called COVID-19. Certain infection control precautions are needed to protect immunocompromised and vulnerable patients, including liver transplant candidates and recipients from acquiring COVID-19 infection. Restricting non-transplant elective surgical procedures, managing transplant patients in separate outpatient clinics, and in-patient wards can prevent transmission of infection both to patients and healthcare workers. Telemedicine can help in the triage of patients to screen for symptoms of COVID-19 before their regular appointment. Management of immunosuppressive therapy and drug-drug interactions in liver transplant recipients infected with COVID-19 should be cautiously practiced to prevent rejection and effectively treat the underlying infection. In this report, we are trying to summarize available evidence about different aspects of the management of liver transplant candidates and recipients in the era of COVID-19.","Arab J Gastroenterol","El Kassas, Mohamed","Alboraie, Mohamed","Al Balakosy, Amira","Abdeen, Nermeen","Afify, Shimaa","Abdalgaber, Mohammad","Sherief, Ahmed F","Madkour, Ahmad","Abdellah Ahmed, Mohamed","Eltabbakh, Mohamed","Salaheldin, Mohamed","Wifi, Mohamed-Naguib","32439237"],"abstract":["Liver transplantation is considered the ultimate solution for patients with end-stage chronic liver disease or acute liver failure. Patients with liver transplant need special care starting from preoperative preparation, surgical intervention ending with postoperative care. Transplanted patients have to receive immunosuppressive therapy to prevent rejection. Such a state of immune suppression could predispose to different types of infections in liver transplant recipients. Currently, the world is suffering a pandemic caused by a new strain of the coronavirus family called COVID-19. Certain infection control precautions are needed to protect immunocompromised and vulnerable patients, including liver transplant candidates and recipients from acquiring COVID-19 infection. Restricting non-transplant elective surgical procedures, managing transplant patients in separate outpatient clinics, and in-patient wards can prevent transmission of infection both to patients and healthcare workers. Telemedicine can help in the triage of patients to screen for symptoms of COVID-19 before their regular appointment. Management of immunosuppressive therapy and drug-drug interactions in liver transplant recipients infected with COVID-19 should be cautiously practiced to prevent rejection and effectively treat the underlying infection. In this report, we are trying to summarize available evidence about different aspects of the management of liver transplant candidates and recipients in the era of COVID-19."],"journal":"Arab J Gastroenterol","authors":["El Kassas, Mohamed","Alboraie, Mohamed","Al Balakosy, Amira","Abdeen, Nermeen","Afify, Shimaa","Abdalgaber, Mohammad","Sherief, Ahmed F","Madkour, Ahmad","Abdellah Ahmed, Mohamed","Eltabbakh, Mohamed","Salaheldin, Mohamed","Wifi, Mohamed-Naguib"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32439237","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.ajg.2020.04.019","keywords":["covid-19","coronavirus","liver transplantation"],"topics":["Prevention"],"weight":1,"_version_":1667523504770121729,"score":61.163467},{"pmid":32270388,"pmcid":"PMC7140588","title":"Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI).","text":["Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI).","The Liver Transplant Society of India (LTSI) has come up with guidelines for transplant centres across the country to deal with liver transplantation during this evolving pandemic of COVID-19 infection. The guidelines are applicable to both deceased donor as well as living donor liver transplants. In view of the rapidly changing situation of COVID-19 infection in India and worldwide, these guidelines will need to be updated according to the emerging data.","Hepatol Int","Saigal, Sanjiv","Gupta, Subash","Sudhindran, S","Goyal, Neerav","Rastogi, Amit","Jacob, Mathew","Raja, Kaiser","Ramamurthy, Anand","Asthana, Sonal","Dhiman, R K","Singh, Balbir","Perumalla, Rajasekhar","Malik, Ashish","Shanmugham, Naresh","Soin, Arvinder Singh","32270388"],"abstract":["The Liver Transplant Society of India (LTSI) has come up with guidelines for transplant centres across the country to deal with liver transplantation during this evolving pandemic of COVID-19 infection. The guidelines are applicable to both deceased donor as well as living donor liver transplants. In view of the rapidly changing situation of COVID-19 infection in India and worldwide, these guidelines will need to be updated according to the emerging data."],"journal":"Hepatol Int","authors":["Saigal, Sanjiv","Gupta, Subash","Sudhindran, S","Goyal, Neerav","Rastogi, Amit","Jacob, Mathew","Raja, Kaiser","Ramamurthy, Anand","Asthana, Sonal","Dhiman, R K","Singh, Balbir","Perumalla, Rajasekhar","Malik, Ashish","Shanmugham, Naresh","Soin, Arvinder Singh"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270388","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s12072-020-10041-1","locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1666138491797372928,"score":60.925144}]}